Genentech Drug Patent Portfolio

Genentech owns 4 orange book drugs protected by 7 US patents Given below is the list of Genentech's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9278961 Pyridyl inhibitors of hedgehog signalling 15 Dec, 2028
Active
US7888364 Pyridyl inhibitors of hedgehog signalling 11 Nov, 2028
Active
US9790183 Pyridyl inhibitors of hedgehog signalling 02 Sep, 2025
Active
US5763394 Human growth hormone aqueous formulation 09 Jun, 2015 Expired
US5654010 Composition for sustained release of human growth hormone 05 Aug, 2014 Expired
US5656297 Modulated release from biocompatible polymers 25 Jul, 2014 Expired
US6051259 Composition for sustained release of human growth hormone 02 Dec, 2012 Expired


Given below is the list of recent legal activities going on the following drug patents of Genentech.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 8th Year, Large Entity 23 Aug, 2023 US9278961
Payment of Maintenance Fee, 12th Year, Large Entity 03 Aug, 2022 US7888364
Payment of Maintenance Fee, 4th Year, Large Entity 31 Mar, 2021 US9790183
Payment of Maintenance Fee, 4th Year, Large Entity 22 Aug, 2019 US9278961
Payment of Maintenance Fee, 8th Year, Large Entity 02 Aug, 2018 US7888364
Mail O.P. Petition Decision 11 May, 2018 US9790183
Mail-Record a Petition Decision of Granted to Issue Patent in Name of the Assignee 09 May, 2018 US9790183
O.P. Petition Decision 08 May, 2018 US9790183
Record a Petition Decision of Granted to Issue Patent in Name of the Assignee 08 May, 2018 US9790183
Post Issue Communication - Certificate of Correction 08 Nov, 2017 US9790183
Petition Entered 31 Oct, 2017 US9790183
Recordation of Patent Grant Mailed 17 Oct, 2017 US9790183
Patent Issue Date Used in PTA Calculation 17 Oct, 2017 US9790183
Email Notification 28 Sep, 2017 US9790183
Issue Notification Mailed 27 Sep, 2017 US9790183


Genentech's Family Patents

Genentech drugs have patent protection in a total of 24 countries. It's US patent count contributes only to 16.4% of its total global patent coverage. 1 country has all of their patents expired or invalidated which has opened up potential generic launch opportunities in this particular country. Click below to unlock the full patent family tree.

Family Patents



Genentech Drug List

Given below is the complete list of Genentech's drugs and the patents protecting them.


1. Erivedge

Erivedge is protected by 3 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9278961 Pyridyl inhibitors of hedgehog signalling 15 Dec, 2028
(4 years from now)
Active
US7888364 Pyridyl inhibitors of hedgehog signalling 11 Nov, 2028
(4 years from now)
Active
US9790183 Pyridyl inhibitors of hedgehog signalling 02 Sep, 2025
(10 months from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Erivedge's drug page


2. Nutropin Aq

Nutropin Aq is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5763394 Human growth hormone aqueous formulation 09 Jun, 2015
(9 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Nutropin Aq's drug page


3. Nutropin Aq Pen

Nutropin Aq Pen is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5763394 Human growth hormone aqueous formulation 09 Jun, 2015
(9 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Nutropin Aq Pen's drug page


4. Nutropin Depot

Nutropin Depot is protected by 3 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5654010 Composition for sustained release of human growth hormone 05 Aug, 2014
(10 years ago)
Expired
US5656297 Modulated release from biocompatible polymers 25 Jul, 2014
(10 years ago)
Expired
US6051259 Composition for sustained release of human growth hormone 02 Dec, 2012
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Nutropin Depot's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Genentech News

Lilly's Focus on Direct-to-Consumer Marketing for Obesity, Job Cuts, and Interest in Eye Conditions - BioSpace

04 Sep, 2024

Italy initiates antitrust investigation against Novartis, Roche, and other companies for alleged collaboration in postponing ...

06 Jun, 2024

See More